T1	Pharmacological_substance 38 50	methotrexate
N1000 	Reference T1 MeSH:D008727	methotrexate
T2	Disorder 63 92	juvenile rheumatoid arthritis
N1 	Reference T2 UMLS:C3495559	juvenile rheumatoid arthritis
N2 	Reference T2 UMLS:C3714757	juvenile rheumatoid arthritis
T4	Disorder 153 202	polyarticular-onset juvenile rheumatoid arthritis
N3 	Reference T4 UMLS:C0003873	polyarticular-onset juvenile rheumatoid arthritis
T5	Pharmacological_substance 250 262	methotrexate
N1001 	Reference T5 MeSH:D008727	methotrexate
T6	Pharmacological_substance 397 409	methotrexate
N1002 	Reference T6 MeSH:D008727	methotrexate
T7	Pharmacological_substance 478 490	methotrexate
N1003 	Reference T7 MeSH:D008727	methotrexate
T8	Pharmacological_substance 553 571	hydroxychloroquine
N1004 	Reference T8 MeSH:D006886	hydroxychloroquine
T9	Pharmacological_substance 620 632	methotrexate
N1005 	Reference T9 MeSH:D008727	methotrexate
T10	Disorder 637 666	juvenile rheumatoid arthritis
N4 	Reference T10 UMLS:C3495559	juvenile rheumatoid arthritis
N5 	Reference T10 UMLS:C3714757	juvenile rheumatoid arthritis
T13	Disorder 21 30	nodulosis
T14	Subject 107 119	two patients
T16	Disorder 223 232	nodulosis
T18	Disorder 327 344	nodules increased
N6 	Reference T18 UMLS:C0028259	nodules increased
T20	Disorder 440 447	nodules
N7 	Reference T20 UMLS:C0028259	nodules
